Renovorx Stock Ten Year Return
| RNXT Stock | USD 1.21 0.08 6.20% |
RenovoRx fundamentals help investors to digest information that contributes to RenovoRx's financial success or failures. It also enables traders to predict the movement of RenovoRx Stock. The fundamental analysis module provides a way to measure RenovoRx's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to RenovoRx stock.
RenovoRx | Ten Year Return |
RenovoRx Company Ten Year Return Analysis
RenovoRx's Ten Year Return shows the total annualized return generated from holding a fund for the last 10 years and represents fund's capital appreciation, including dividends losses and capital gains distributions. This return indicator is considered by many investors to be the ultimate measures of fund performance and can reflect the overall performance of the market or market segment it invests in.
More About Ten Year Return | All Equity Analysis
Ten Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
RenovoRx Ten Year Return Driver Correlations
Understanding the fundamental principles of building solid financial models for RenovoRx is extremely important. It helps to project a fair market value of RenovoRx Stock properly, considering its historical fundamentals such as Ten Year Return. Since RenovoRx's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of RenovoRx's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of RenovoRx's interrelated accounts and indicators.
Click cells to compare fundamentals
Although Ten Year Fund Return indicator can give a sense of overall fund long-term potential, it is recommended to compare funds performances against other similar funds or market benchmarks for the same 10-year interval.
| Competition |
RenovoRx Return On Tangible Assets
Return On Tangible Assets |
|
Based on the latest financial disclosure, RenovoRx has a Ten Year Return of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
RenovoRx Ten Year Return Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses RenovoRx's direct or indirect competition against its Ten Year Return to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of RenovoRx could also be used in its relative valuation, which is a method of valuing RenovoRx by comparing valuation metrics of similar companies.RenovoRx is currently under evaluation in ten year return category among its peers.
RenovoRx Fundamentals
| Return On Equity | -1.55 | ||||
| Return On Asset | -0.7 | ||||
| Current Valuation | 19.48 M | ||||
| Shares Outstanding | 24 M | ||||
| Shares Owned By Insiders | 1.90 % | ||||
| Shares Owned By Institutions | 8.18 % | ||||
| Number Of Shares Shorted | 71.85 K | ||||
| Price To Book | 4.11 X | ||||
| EBITDA | (11.39 M) | ||||
| Net Income | (10.23 M) | ||||
| Cash And Equivalents | 10.77 M | ||||
| Cash Per Share | 1.19 X | ||||
| Total Debt | 4.47 M | ||||
| Current Ratio | 10.01 X | ||||
| Book Value Per Share | (0.28) X | ||||
| Cash Flow From Operations | (10.26 M) | ||||
| Short Ratio | 3.43 X | ||||
| Earnings Per Share | (0.58) X | ||||
| Target Price | 5.25 | ||||
| Beta | 0.99 | ||||
| Market Capitalization | 29.04 M | ||||
| Total Asset | 1.47 M | ||||
| Retained Earnings | (41.41 M) | ||||
| Working Capital | 291 K | ||||
| Net Asset | 1.47 M |
About RenovoRx Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze RenovoRx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of RenovoRx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of RenovoRx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for RenovoRx Stock Analysis
When running RenovoRx's price analysis, check to measure RenovoRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RenovoRx is operating at the current time. Most of RenovoRx's value examination focuses on studying past and present price action to predict the probability of RenovoRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RenovoRx's price. Additionally, you may evaluate how the addition of RenovoRx to your portfolios can decrease your overall portfolio volatility.